Skip to content

Clinical trials

Observational Smoldering Multiple Myeloma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Smoldering Multiple Myeloma Phase: Observational Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20101
20142
20151
20161
20182
20201
20211
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed2
Active, not recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Dana-Farber Cancer Institute2
M.D. Anderson Cancer Center2
Tufts Medical Center2
Wake Forest University Health Sciences2
HealthTree Foundation1
Indiana University1
National Cancer Institute (NCI)1
SWOG Cancer Research Network1
UNC Lineberger Comprehensive Cancer Center1
University of Miami1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Smoldering Multiple Myeloma15
Monoclonal Gammopathy of Undetermined Significance11
Multiple Myeloma8
Waldenstrom Macroglobulinemia4
Immunoglobulin Light-chain Amyloidosis3
Amyloidosis2
Hematologic Neoplasms2
Leukemia, Lymphocytic, Chronic, B-Cell2
Neoplasms, Plasma Cell2
Castleman Disease1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.